Novoprotein Scientific Inc.

¥126.60As of Sun 8 Nov 2026, 12:00 UTC
SSE:688137Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR 14.13%
Div yield —
ROE (4.77%)
Biotechnology
Beta (5Y) 1.25
PE TTM —
TSR TTM 182.34%
Mkt cap ¥8.800B
ROIC (11.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥135
6.82%
(30.45%)
Hold 11|2|8|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.87
1.85
1.90
2.07
20.48%
11.83%
13.18%
18.17%
Revenue¥B
1.020
1.016
1.073
1.121
(1.01%)
(5.53%)
0.55%
7.37%
Peers (US$1.319B)
Cap (US$)
PE
1.316B
122.1x
1.308B
39.02x
1.343B
—
Capital
TTM
5Y
10Y
Leveragex
0.528
1.867
1.305
EBIT/Intx
6.705
0.417
0.409
Own earn%
37.16
(51.53)
(31.56)
Sh yield%
22.10
47.42
46.39
Owners
Insiders/Inst%
13.82
58.52
Short interest%
3.69
SBC / revenue%
1.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
12–17
$1 testx
−0.1
Incr. ROIC%
1